Mycoplasma hominis was highly susceptible to two new quinolones, with MICs for 90% of isolates tested of 0.004 ,ug/ml for WIN 57273 and 0.063 ,ug/ml for sparfloxacin, which were activities much greater than the 1 ,Lg/ml found for ofioxacin and tetracycline. Although Ureaplasma urealyticum was less susceptible, the MICs for 90% of isolates tested of 0.25 ,ug/ml for WIN 57273 and 0.5 ,Lg/ml for sparfloxacin were four-to eightfold greater than those found for ofloxacin (2 ,ug/ml) and tetracycline (2 ,Lg/ml). The finding that U. urealyticum and M. hominis are more susceptible to WIN 57273 and sparfloxacin than they are to other quinolones suggests that these quinolones may be therapeutically useful.
The susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to the newer quinolones roughly parallel the activities seen with grampositive bacteria (1, 3, 4) . In our previous study, the MICs of some of the more active quinolones for 90% of M. hominis isolates tested (MIC90s) were as follows: ciprofloxacin, 1 ptgIml; difloxacin, 1 pug/ml; and ofloxacin, 2 ,ug/ml (4) . For U.
urealyticum, the MIC90s were as follows: ciprofloxacin, 16 ,ug/ml; difloxacin, 2 p.g/ml; and ofloxacin, 2 ,ug/ml. The levels which can be achieved in blood and tissue upon administration of these quinolones (9) are close to these MICs, except for the levels of ciprofloxacin against U. urealyticum. Recently, two new quinolones, sparfloxacin (CI-978, AT 4140) and WIN 57273, have shown much superior activity for gram-positive bacteria (1, 5) and, hence, may be more useful for mycoplasmas. Accordingly, we determined the susceptibilities of U. urealyticum and M. hominis to sparfloxacin and WIN 57273 by using ofloxacin as a reference to link the present data to those of our previous study (4) .
The strains of M. hominis and U. urealyticum were the same as those used previously (4) . The methods for determining the MICs by agar dilution also have been described previously (4) . Ureaplasmas were tested on U agar, and M. hominis was grown on H agar (2) . In an atmosphere of 5% CO2 in air at 37°C, the pH of H agar was 7.2 and that of U agar was 6.2. The MIC was defined as that amount of antimicrobial agent which completely prevented the formation of 30 to 300 colonies per spot in 3 and 4 days for U. urealyticum and 5 days for M. hominis (4). The following quinolones were used: sparfloxacin (CI-978, AT 4140; Parke Davis, Ann Arbor, Mich.), WIN 57273 (Sterling Research Group, Rensselaer, N.Y.), and ofloxacin (Ortho Pharmaceutical Co., Raritan, N.J.). Tetracycline was obtained from Sigma Chemical Co., St. Louis, Mo. Solutions of antimicrobial agents were prepared on the day of the experiment. Quinolones were solubilized by adding 0.025 ml of 10 N NaOH to 10 mg of quinolone suspended in 10 ml of water. Tetracycline was water soluble. Antimicrobial agents were sterilized by filtration through a 0.22-,um-pore-size filter (Millipore Corp., Bedford, Mass. urealyticum was less susceptible: the MIC90 was 0.25 ,ug/ml for WIN 57273, 0.5 pug/ml for sparfloxacin, and 2.0 ,ug/ml for both tetracycline and ofloxacin (Table 1) . We tested the susceptibilities of three strains of U. urealyticum and nine strains of M. hominis which contained the tetracycline resistance element, Tet M (6, 7). These strains were highly resistant to tetracycline (.32 ,ug/ml), but their susceptibilities to sparfloxacin, WIN 57273, and ofloxacin were the same as those for strains without Tet M. Possibly, the difference in susceptibilities between U. urealyticum and M. hominis might be due to the pH, because the two species were tested at different pHs. Although U. urealyticum grows poorly at pH 7.2, M. hominis grows well at both pH 7.2 and pH 6.2. We compared the MICs for 10 M. hominis strains on both H agar and U agar at the same time. The H agar and U agar were from the same lot of soy peptone base. The only difference between the media was the addition of urea and 2-(N-morpholino)ethansulfonic acid buffer (MES) to the U agar (2) . On U agar (pH 6.2), M. hominis was one twofold dilution more susceptible to WIN 57273 than it was on H agar (pH 7.2). By contrast, it was one twofold dilution less susceptible to ofloxacin at pH 6.2, a result similar to that found for ciprofloxacin in our previous study (4) . The susceptibility of M. hominis to sparfloxacin was the same at both pHs. Overall, a change in pH from 7.2 to 6.2 had only small effects on the susceptibilities of mycoplasmas to the quinolones tested in this study.
In a previous study (4), M. hominis was usually a 2-fold dilution more susceptible to all quinolones except ciprofloxacin than U. urealyticum was; it was 16-fold more susceptible to ciprofloxacin than U. urealyticum was (MIC90). In the present study ( 
